Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Literature
1.
Ismail G, Obrişcă B, Jurubţă R, Andronesi A, Sorohan B, Hârza M (2020) Inherited risk factors of thromboembolic events in patients with primary nephrotic syndrome. Medicina (Kaunas, Lithuania) 56:242CrossRef
2.
Haapaniemi E, Helenius J, Jakovljević D, Soinne L, Syrjälä M, Kaste M et al (2009) Ischaemic stroke patients with heterozygous factor V Leiden present with multiple brain infarctions and widespread atherothrombotic disease. Thromb Haemost 101:145–150CrossRef
3.
Kannan M, Yadav BK, Ahmad F, Biswas A, Saxena R (2009) Modulation of clinical phenotype of Glanzmann’s thrombasthenia by thrombogenic mutations. Clin Chim Acta 403:156–158CrossRef
4.
5.
Hotoleanu C, Trifa A, Popp R, Fodor D (2013) The importance of homozygous polymorphisms of methylenetetrahydrofolate reductase gene in romanian patients with idiopathic venous thromboembolism. Balkan Med J 30:197–203CrossRef
Metadata
Title
Study of Prothrombotic Gene Variations Associated with the Risk of Development of Thrombosis in Patients with Down Syndrome
Authors
Chandreswara Raju Kataru
Vinodhini Krishnakumar
Inusha Panigrahi
Meganathan Kannan
Publication date
01-07-2021
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2021
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-020-01369-7

Other articles of this Issue 3/2021

Indian Journal of Hematology and Blood Transfusion 3/2021 Go to the issue

Short Communication

Does Mesenchymal Stromal Cell Count in Pre-autologous Hematopoietic Stem Cell Transplant Peripheral Blood and Apheresis Product Predict for Infectious Complications in the Post-transplant Period?

Original Article

Myeloablative Versus Reduced Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Retrospective Analysis

Original Article

Haploidentical Hematopoietic Stem Cell Transplantation in Leukemia’s: Experience from a Cancer Center in India

Original Article

Real-world Experience of Rituximab in Immune Thrombocytopenia

Original Article

Design and Development of Reverse Slot Blot for the Simultaneous Detection of Rare and Regional Specific Mutations in the Beta Globin Gene in Khuzestan Province of Iran

Original Article

Role of Using a Thromboelastometry-Based Protocol for Transfusion Management in Combined Coronary Artery Bypass Grafting and Valve Surgery: A Randomized Clinical Trail
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits